Extracerebellar primitive neuroectodermal tumors: A clinicopathologic study with bcl-2 and CD99 immunohistochemistry

Area of Science:

• Neuro-oncology
• Pediatric Pathology
• Molecular Biology

Background:

• Supratentorial primitive neuroectodermal tumors (S-PNETs) are rare pediatric brain tumors, histologically similar to cerebellar medulloblastomas.
• The cell of origin and histogenesis of S-PNETs remain poorly understood, leading to controversy regarding their relationship with other embryonal neoplasms.
• S-PNETs exhibit divergent differentiation, including neuronal, glial, and mesenchymal lines.

Purpose of the Study:

• To investigate the potential role of bcl-2 and CD99 as markers in S-PNETs.
• To clarify the histogenesis and cell of origin of S-PNETs.
• To explore the pathogenetic mechanisms and potential for apoptosis inhibition in S-PNETs.

Main Methods:

• Immunohistochemical analysis of eight S-PNETs using antibodies against bcl-2 and CD99.
• Evaluation of tumor differentiation patterns (neuronal, glial, none).
• Correlation of immunohistochemical findings with patient outcomes.

Main Results:

• None of the S-PNETs stained positive for CD99, suggesting they are distinct from peripheral embryonal tumors.
• Three of eight S-PNETs showed focal, strong cytoplasmic staining for bcl-2, particularly those with neuronal and astrocytic differentiation.
• Tumor differentiation varied, with no differentiation in two, neuronal only in two, and both neuronal and glial in four cases.

Conclusions:

• Bcl-2 positivity in S-PNETs may indicate a subgroup with inhibited apoptosis as a pathogenetic mechanism.
• CD99 staining patterns suggest supratentorial and peripheral embryonal tumors are distinct pathogenetic entities.
• Further research is needed to fully elucidate the relationship between bcl-2 staining and neuronal differentiation in S-PNETs.